New Paper – Targeting Alzheimer’s disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil.
A new paper from our drug discovery team has been published in the European Journal of Medicinal Chemistry detailing the identification of novel analogues of the cholinesterase inhibitor Donepezil for the potential treatment of Alzheimer’s disease. Congratulations to Divan van Greunen who was the lead chemist on the research reported. You can read the article …
